首页
登录
职称英语
Last year, when President George W. Bush announced that federal funds could
Last year, when President George W. Bush announced that federal funds could
游客
2025-04-08
41
管理
问题
Last year, when President George W. Bush announced that federal funds could be used to support research on human embryonic stem cells, he mandated that only those cell lines that existed at the time would qualify for such support. More than a year later, it’s becoming increasingly clear that these existing cell lines are inadequate. Unless more are created, the research slowdown may exact a staggering cost in terms of human suffering.
Since this announcement, the US National Institutes of Health has tried to stimulate research on. the existing cell lines with new funding and efforts to streamline the initially cumbersome process of obtaining approved cells. However, whether there are 60 cell lines, as originally stated, or nine, as now appear to be available to NIH-funded investigators, the number is not adequate. Given the genetic diversity within the population, scientists need access to new cell lines if they are to come up with the most effective cell therapies.
The issue is partly one of safety. In conducting research with human participants, we must minimize risks. The most effective cell line might not be the safest. When developing a new medicine, a large number of molecules must be screened to find a balance between effectiveness and safety. The same is true with cells. In the context of cell therapy, it will be important to minimize unwanted immune reactions and inflammation this requires selection from a large number of cell lines to obtain the best match.
It’s clear from experiments with animals that stem-cell therapies can reduce human suffering as Parkinsonian mice have been cured with embryonic stem cells that were programmed to become dopamine-secreting, replacement nerve ceils. Soon, cells induced to make insulin in tissue cultures will be used in attempts to treat diabetic mice. Similar successes have been achieved in animal models of spinal-cord injury, heart failure and other degenerative disorders. We are at a frontier in medicine where tissues will be restored in ways that were not imaginable just a few years ago. The ethical issues raised by human-embryo research are profound. The human costs of restricting this research must be taken into account as well. The cost in dollars of delaying new stem-cell research is difficult to estimate. It might measure in the hundreds of billions of dollars, especially if one adds the lost productivity of individuals who must leave work to care for victims of degenerative disorders.
A less obvious, but real, cost is the damage to the fabric of America’s extraordinary culture of inquiry and technical development in biomedical science. Our universities and teaching hospitals are unparalleled. We attract the very best students, scientists and physicians from around the world. But these institutions are fragile. Research and education play key roles in attracting the best physicians. A crippled research enterprise might add an unbearable stress with long-lasting effects on the entire system. If revolutionary new therapies are delayed or outlawed, we could be set back for years, if not decades.
To steer clear of controversy, some investigators will redirect their research. Others will emigrate to countries where such research is allowed and encouraged. Some will drop out entirely. The pall cast over the science community could extend far beyond stem-cell research. Many therapies have emerged from collaboration between government-sponsored researchers and private enterprise. Few of these discoveries would have emerged if, for instance, recombinant DNA research had been outlawed 30 years ago. We face the same type of decision today with limits placed on human embryonic stem cells. Safeguards will be necessary. But if we do not proceed embracing the values of objective, open, inquiry with complete sharing of methods and results, the field will be left to less rigorous fringe groups here and abroad. Patients and society will suffer. [br] The word "streamline" in Paragraph 2 probably means______.
选项
A、strengthen
B、simplify
C、ascertain
D、subvert
答案
B
解析
语义题。根据题干定位到原文第二段首句。其中cumbersome表示“讨厌的,麻烦的,笨重的”。既然原来的过程是很繁琐的,那需要做的就是简化这一过程。故答案为B。
转载请注明原文地址:https://tihaiku.com/zcyy/4031386.html
相关试题推荐
TheFederalGovernment______farmersbybuyingtheirsurpluscropsatpricesabov
NowtheythinkthattheirviewsaboutthepresidentandhispoliciesonIraq,gl
AnyDemocraticpresidentwilltryto_____theUnitedStatesfromthemessinIraq
In1784,fiveyearsbeforehebecamepresidentoftheUnitedStates,GeorgeWa
In1784,fiveyearsbeforehebecamepresidentoftheUnitedStates,GeorgeWa
In1784,fiveyearsbeforehebecamepresidentoftheUnitedStates,GeorgeWa
GeorgeMasonmustrankwithJohnAdamsandJamesMadisonasoneofthethree
Thepresidentofthecollege,togetherwiththedeans,____aconferenceforthep
AlongtimeaidetoPresidentBushwhowroteoccasionalguestcolumnsforhis
AlongtimeaidetoPresidentBushwhowroteoccasionalguestcolumnsforhis
随机试题
【B1】[br]【B2】A、seesB、looksC、lookslikeB这里考察动词用法,see意为“看见”•,look意为“看起采
1 Hawaii’snativeminorityisdemandingagreaterdegreeofsovereigntyoverit
______isNOTaplaywright.A、BenJohnsonB、ShakespeareC、EdmundSpenserD、Christo
超声生物学效应中不包括A.致热作用 B.空化作用 C.电离作用 D.实验研
某同学用单色光进行双缝干涉实验,在屏上观察到如图甲所示的条纹。仅改变一个实验条件
下列哪项在心主血脉中起关键作用?( )A.心血充盈 B.心气充沛 C.心神
若醋的用量较少,不能与药物拌匀时,可以A.适当增加用醋量B.加适量水稀释C.加适
患者男性,50岁,赴宴饱餐后不久突然感到胸骨后持续性压榨样疼痛3小时,向左颈和肩
某承台下设三根桩,桩径为600mm,钻孔灌注桩(干作业),桩长11m,各层土的厚
具有缓释作用的是()A.水丸 B.蜜丸 C.糖丸 D.蜡丸 E.滴丸
最新回复
(
0
)